Live Breaking News & Updates on Melanie Toyne Sewell Phil Marriage Life Sciences

(0)
Fund launched in July 2020 invests in late-stage European life science companies
Fund now closed at the hard cap, with investors that include Pantheon, Eli Lilly and Company, Horizon Therapeutics plc (Nasdaq: HZNP), the Belgian Growth Fund, New Waves Investments, Wealth Management Partners, KfW Capital and the European Investment Fund (EIF)
First three investments made from fund
Forbion, a leading European life sciences venture capital firm, today announces the final close of its Forbion Growth Opportunities Fund I ( Forbion Growth I ) at the hard cap amount of EUR 360 million (USD 428 million). Forbion Growth I is focused on investing in late-stage European life sciences companies. ....

United States , United Kingdom , Kostenloser Wertpapierhandel , Sander Slootweg , Eli Lilly , Werner Lanthaler , Tim Van Hauwermeiren , Dezima Pharma , Dirk Kersten , Moelis Co , European Recovery Programme , European Investment Fund , Belgian Growth Fund , Forbion Growth Opportunities Fundi , Advisory Group , Life Sciences , Dutch Venture Initiative , Melanie Toyne Sewell Phil Marriage Life Sciences , Horizon Therapeutics , New Waves Investments , Wealth Management Partners , Kfw Capital , Maarten De Jong , Synox Therapeutics , New Amsterdam Pharma , Gyroscope Therapeutics ,